Addiction Medicine Rounds

Brief description:

The Yale Addiction Medicine (AM) Rounds are held the second Thursday of every month on the School of Medicine campus. The content of the AM Rounds covers a range of topics relevant to Addiction Medicine including research, education, training and clinical care. As the field of Addiction Medicine continues to rapidly evolve, with Yale at the forefront, the AM Rounds has proven to be an exciting venue for discussion and interaction among all involved individuals including students, residents, fellows, and junior and senior faculty. In addition to allowing each of us to disseminate our work, the AM Rounds has provided a venue to forge and strengthen collaboration.

We are pleased to announce that Addiction Medicine Rounds are now CME accredited. Each session will be assigned 1 AMA PRA Category 1 Credits™.

When and Where:

***Please note Rounds have changed times! The new time is reflected below, in bold.***

Second Thursday of every month, 2:00-3:00pm
Location: Boyer Center Room 206
Boyer Center for Molecular Medicine
295 Congress Ave
New Haven, CT 06510

Upcoming Rounds:

DATETOPICPRESENTER
June 8, 2017Innovations in Emergency Department interventions for Substance Use Disorders: Saving LivesGail D’Onofrio, MD, MS

Prior Rounds:
DATETOPICPRESENTER
May 11, 2017Tobacco Control in the Hospital Emergency DepartmentSteven Bernstein, MD
April 13, 2017An investigation of an open-access model for scaling up methadone maintenance treatmentDeclan Barry, PhD & Lynn Madden, MPA
March 9, 2017Hepatitis C and HIV in Substance Users: Economics of Screening and Linkage to CareBruce R Schackman, PhD
January 12, 2017Meeting the Challenges of the Intersection of Dependency, Substance Misuse and Palliative careJennifer Kapo, MD
December 18, 2016Progesterone for postpartum women with a cocaine use disorderKimberly Yonkers, MD
November 10, 2016What would happen if insurance cost more for those who smoked cigarettes?: Lessons from the Affordable Care ActSusan Busch, PhD
October 13, 2016Cognitive Function as a Novel Treatment Target for Drug AddictionMehmet Sofuoglu, MD, PhD
September 8thExtended-release naltrexone reduces alcohol consumption and maintains VL suppression and among released prisoners living with HIV after release to the community: Results of a randomized controlled trialSandra Springer, MD
Oct 8Opioid Overdose in Connecticut – Epidemiology, Prevention and Therapeutic OptionsLauretta Grau, PhD, and Kate Hawk, MD
Nov 12Hepatitis C treatment in patients with SUD: National models and local trendsJeanette Tetrault, MD
Dec 10Medical Toxicology of Emerging Drugs of AbuseAsim Tarabar, MD
Jan 14Treating smoking and heavy drinking: Integrated treatment strategiesLisa Fucito, PhD
Feb 11Chronic pain and high-risk opioid use: Diagnostic and treatment challengesWilliam Becker, MD
Mar 10Sex Differences In Medication Response for Smoking CessationSherry Mckee, PhD
Apr 14Behavioral AddictionsMarc Potenza, MD, PhD
May 19Suburban Injection Drug UseRobert Heimer, PhD
June 9The Rhode Island Strategic Plan on Opioid Addiction and OverdoseJody Rich, MD and Traci Green, PhD
July 14Opioid Agonist Treatment in the Connecticut Department of CorrectionKathleen Maurer, M.D.